Seven years of qualification
Audited Supplier
In This Store
Chirogate is a leading US-FDA inspected Prostaglandin (PG) manufacturer and owns more than 6 dedicated & cGMP-compliant production lines for cutting-edged manufacturing of PGs. Several process patents filed and granted worldwide are to provide a commercially revolutionary synthetic approach and an exciting spectrum of advanced intermediates for synthesis of new PG entities. US DMFs filed for Treprostinil, Latanoprost, Bimatoprost, and Travoprost with additional registration experiences in China, Japan, Canada, Australia, New Zealand and major EU countries. Products: Treprostinil, Treprostinil Sodium & Dienthanolamine, Beraprost Sodium (& 314d), Iloprost (& Tromethamine), Carboprost Tromethamine, Latanoprost, Latanoprostene Bunod, Bimatoprost, Travoprost, Misoprostol(& 1% HPMC), Lubiprostone, Dinoprostone, Tafluprost, Alprostadil, Dinoprost (& Tromethamine), and (+)-Cloprostenol (&Sodium).
Year of Establishment: 1999
Total Assets(USD):
Total Number of Staff: 100-500
Main Competitive Advantages: International Approvals/Standards,Experienced R&D Staff,Production Capacity,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages:
Patents and Copyrights: US 7,511,168 US 7,582,779 US 7,626,024 US 8,030,514 US 8,350,090 US 8,524,939 US 8,658,837 US 9,115,109 US 10,253,011 EP 1,811,037
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us：
Pharma Sources Insight June 2024: Globalization on the Go
